1-8 of 8
Rutul R. Shah
Close
Sort by
Journal Articles

A Phase1/1b Dose Escalation/Dose Expansion Study of Prgn-3007 Ultracar-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies

Javier Pinilla Ibarz, Amy Lankford, Helen Sabzevari, Bijal D. Shah, Hatem Soliman, Julio C. Chavez, Rutul R Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 7486–7487.
https://doi.org/10.1182/blood-2022-168932
Published: 2022
Journal Articles

Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

David A. Sallman, Hany Elmariah, Kendra Sweet, Chetasi Talati, Asmita Mishra, Cheryl A Cox, Roshanak Semnani, Rutul R Shah, Helen Sabzevari, Marion Chakiath, Justin Uthuppan, Amy Lankford, Chen Wang, Eric Padron, Andrew T. Kuykendall, Rami S. Komrokji, Jeffrey E. Lancet, Marco L. Davila, Nelli Bejanyan
Journal: Blood
Blood (2021) 138 (Supplement 1): 825.
https://doi.org/10.1182/blood-2021-152692
Published: 2021
Journal Articles

Preclinical Evaluation of Prgn-3007, a Non-Viral, Multigenic, Autologous ROR1 Ultracar-T ® Therapy with Novel Mechanism of Intrinsic PD-1 Blockade for Treatment of Hematological and Solid Cancers

Tim Chan, Sean P Scott, Mengyan Du, Cheryl Bolinger, Carol Poortman, Lindsey Shepard, Byron Koenitzer, Adeline Govekung, Carlos Sailor, Rahim Johnson, Jacques Plummer, Steven Zilko, Shourik Dutta, Kannan Kunchithapautham, Taranjit Athwal, Bernward Klocke, Christian Zinser, Maha Abdeladhim, Shamim Ahmad, Simon Metenou, Roshanak Semnani, Douglas E Brough, Rutul R Shah, Helen Sabzevari
Journal: Blood
Blood (2021) 138 (Supplement 1): 1694.
https://doi.org/10.1182/blood-2021-149203
Published: 2021
Journal Articles

A Phase 1/1b Safety Study of Prgn-3006 Ultracar-T™ in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome

David A. Sallman, MD, Hany Elmariah, MD MS, Kendra L. Sweet, MD MS, Chetasi Talati, MD, Asmita Mishra, MD, Linda L. Kelley, PhD, Amy Lankford, PhD, Tim Chan, PhD, Rutul R Shah, Eric Padron, MD, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Helen Sabzevari, PhD, Marco L. Davila, MD PhD, Nelli Bejanyan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-139417
Published: 2020
Journal Articles

Preclinical Characterization of Prgn-3006 Ultracar-T™ for the Treatment of AML and MDS: Non-Viral, Multigenic Autologous CAR-T Cells Administered One Day after Gene Transfer

Tim Chan, PhD, Xiaohong Ma, Fernando Carvajal-Borda, DVM, Jose Velez, Jacques Plummer, Lindsey Shepard, Rutul R Shah, David A Sallman, MD, Helen Sabzevari, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2660.
https://doi.org/10.1182/blood-2019-130617
Published: 2019
Journal Articles

CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies

Tim Chan, PhD, John Gallagher, Nai-Lin Cheng, PhD, Fernando Carvajal-Borda, DVM, Jacques Plummer, Adeline Govekung, John A Barrett, PhD, Pranay D. Khare, PhD, Laurence J N Cooper, MDPhD, Rutul R Shah
Journal: Blood
Blood (2017) 130 (Supplement 1): 1324.
https://doi.org/10.1182/blood.V130.Suppl_1.1324.1324
Published: 2017
Journal Articles

Autologous T Cells Modified to Co-Express CD33-Specific Chimeric Antigen Receptor and a Kill Switch for Treatment of CD33 + Acute Myeloid Leukemia

Degang Song, PhD, Michael H Swartz, Linhua Tian, Fernando Carvajal-Borda, DVM, Jacques Plummer, Rutul R Shah, William G Wierda, MD PhD, Laurence J N Cooper, MDPhD, Tim Chan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1376.
https://doi.org/10.1182/blood.V130.Suppl_1.1376.1376
Published: 2017
Journal Articles

Chimeric Antigen Receptor-Modified T Cells for the Treatment of Acute Myeloid Leukemia Expressing CD33

Degang Song, PhD, Michael H. Swartz, Steve G. Biesecker, Fernando Borda, Rutul R. Shah, Peter Emtage, PhD, William G. Wierda, MD PhD, Laurence J.N. Cooper, MD PhD, Tim Chan, PhD
Journal: Blood
Blood (2016) 128 (22): 4058.
https://doi.org/10.1182/blood.V128.22.4058.4058
Published: 2016